Ernest J. Del Monte Institute for Neuroscience, The University of Rochester Medical CenterRochester, United States
ESH-UKLexington, United States
GRANT Friday, December 15, 2017- 08:30 Human Vaccines Project Two prizes of $150,000. Pre-application due date: February 12, 2018. Apply now. Notification to submit full application: March 5, 2018 Michelson Prizes for Human Immunology and Vaccine Research ...
Lutz, United States
PAPER Otero K, Shinohara M, Zhao H, Cella M, Gilfillan S, Colucci A, Faccio R, Ross FP, Teitelbaum SL, Takayanagi H, Colonna M22312126
University of OxfordOxford, United Kingdom
CONFERENCE COVERAGE 2017-12-15 Conference Coverage Confirming once again that not only anti-amyloid therapeutic approaches struggle to score a win in Alzheimer’s and related dementias, the 10th CTAD conference, held November 1–4 in Boston, featured rest-in-peace presentations on a ...
Financial Economics AssociationGeorgetown, United States
COMMENT This large cohort of presymptomatic C9ORF72 expansion carriers shows a surprising and interesting new finding of lower praxis scores. Future longitudinal studies will be needed to determine whether the early gray-matter and white-matter deficits also seen ...
PAPER Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley R, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz R, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J
CONFERENCE COVERAGE 2017-12-15 Conference Coverage Researchers presented a fall crop of Phase 1 results at the recent Clinical Trials in Alzheimer’s Disease meeting, held November 1–4 in Boston. New treatments aimed at neurotrophin signaling, tau, and cholinergic pathways moved on to ...
PAPER Leijenaar JF, van Maurik IS, Kuijer JP, van der Flier WM, Scheltens P, Barkhof F, Prins ND
Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging.Alzheimers Dement (Amst). 2017;9:76-83. Epub 2017 Nov 2 PubMed: 29234724
No filters selected